Concepedia

123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial

Dimitrios Colevas, Krzysztof Misiukiewicz, Alexander T. Pearson, Jérôme Fayette, Jessica R. Bauman, Didier Cupissol, Esma Saâda-Bouzid, Douglas R. Adkins, Delphine Marie, Stéphanie Cornen,

Annals of Oncology · 2021 · 12 citations · 0 references

DOIFull text

Open access

Concepts